Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Taeyeon Bae
Introduction
Taeyeon Bae is a notable inventor based in Yongin-si, South Korea. He has made significant strides in the field of pain management through his innovative research and development. His work focuses on the SCN9A gene, which plays a crucial role in pain perception.
Latest Patents
Taeyeon Bae holds a patent for an SCN9A antisense pain killer. This invention provides peptide nucleic acid derivatives that target the 3' splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives effectively induce SCN9A mRNA splice variant(s) that lack the SCN9A exon 4 in cells. This innovation is particularly useful for safely treating pains or conditions involving Na1.7 activity.
Career Highlights
Taeyeon Bae is currently associated with Olipass Corporation, where he continues to advance his research in pain management. His dedication to innovation has positioned him as a key figure in the field.
Collaborations
Some of his notable coworkers include Shin Chung and Daram Jung, who contribute to the collaborative efforts at Olipass Corporation.
Conclusion
Taeyeon Bae's contributions to the field of pain management through his innovative patent demonstrate his commitment to improving healthcare solutions. His work is paving the way for new treatments that could significantly enhance the quality of life for individuals suffering from pain.